Unlike single-receptor GLP-1 agonists or dual GIP/GLP-1 agonists, Retatrutide combines three distinct mechanisms into a single peptide
But most of those genes are turned off in our arm because we dont want to grow a heart cell in our arm, right
The potential side-effects of GLP-1 medication have attracted attention
Similar content being viewed by others Introduction Raised intracranial pressure (ICP) is a characteristic of numerous neurological disorders including traumatic brain injury (TBI) [1], stroke [2], subarachnoid haemorrhage [3], hydrocephalus and idiopathic intracranial hypertension (IIH) [4]
Both incorporate glucagon receptor agonism alongside GLP-1 activity, but retatrutide takes this further by adding a third target -- GIP receptor agonism -- making it the first triple-hormone receptor agonist in clinical development
they are simply resting for a while